← Back to Patent Explorer
US6330884B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Deformable scaffolding multicellular stent

Assignee: Medtronic Vascular Inc
•
Filing: 1998-06-02
•
Granted: 2001-12-18
•
Expires: 2018-06-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A plastically deformable stent for implantation within a body passage includes a plurality of cylindrical segments, and a plurality of connectors extending between adjacent segments. Each segment has an alternating pattern of curvilinear elements extending about its circumference, including first and second sets of curvilinear elements having different resistances to expansion, and preferably defining “U” shapes with alternating lengths that are connected to one another to define a substantially sinusoidal pattern. The connectors define a sinusoidal shape adapted to extend and compress axially substantially evenly when the adjacent segments are subjected to bending. The stent may be delivered on a device including an elongate member with a nose cone, an expandable member, and a proximal shoulder thereon, and an outer sheath for slidably receiving the elongate member therein. The outer sheath and/or nose cone may have perfusion holes for allowing continued perfusion of fluid during stent delivery. The device may be used in a method for implanting a stent within a curved region of a body passage, particularly for creating and/or maintaining a channel connecting a vein to an adjacent artery, preferably in the coronary system.

Inventors

  • 👤 Steven W. Kim

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 05:04
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/11; A61B17/12; A61B17/12022; A61B17/12027; A61B17/1204; A61B17/12045; A61B17/12099; A61B17/12109; A61B17/12131; A61B17/12136; A61B17/34; A61B17/3417; A61F; A61F2/00; A61F2/02; A61F2/04; A61F2/06; A61F2/064; A61F2/24; A61F2/2493; A61F2/82; A61F2/86; A61F2/90; A61F2/91; A61F2/915; A61F2/95; A61F2/958; A61B17/00491; A61B17/064; A61B17/0643; A61B18/00; A61B18/04; A61B18/12; A61B18/14; A61B18/1477; A61B18/1492; A61B17/00234; A61B2017/00238; A61B2017/00243; A61B2017/00247; A61B2017/00252; A61B2017/00504; A61B2017/1107; A61B2017/1139; A61B2017/1205; A61B2017/12127; A61B17/30; A61B2017/306; A61B2017/347; A61B2018/00315; A61B2018/00345; A61B2018/00351; A61B2018/00392; A61B2018/1405; A61B2018/1425; A61B90/00; A61B90/40; A61F2/07; A61F2002/061; A61F2/30; A61F2002/30001; A61F2002/30003; A61F2002/3006; A61F2002/30079; A61F2002/825; A61F2002/91508; A61F2002/91525; A61F2002/91533; A61F2002/9155; A61F2002/91558; A61F2002/91575; A61F2002/91591; A61F2210/00; A61F2210/009; A61F2250/00; A61F2250/0014; A61F2250/0048; A61M; A61M25/00; A61M25/0067; A61M25/0074; A61M25/0075; A61M2025/0076; A61M25/0082; A61M25/0084; A61M2025/0089; A61M2025/009; A61M25/10; A61M2025/1043; A61M2025/1052

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 149 words
A method of delivering an expandable stent across a channel connecting a vein to an adjacent artery, the method comprising the steps of: providing a stent delivery device including an elongate member comprising a distal end, the elongate member comprising an expandable member and a nose cone on the distal end, and a stent in a contracted condition on the expandable member; inserting the elongate member into an outer sheath to cover the stent, the outer sheath engaging the nose cone to provide a substantially smooth transition therebetween; advancing the distal end of the elongate member along the vein until the nose cone is advanced into the channel; positioning the stent across the channel; withdrawing the outer sheath proximally to expose the stent within the channel; expanding the stent to an enlarged condition within the channel with the expandable member; and withdrawing the elongate member from the patient's body.
Claim 2
Independent Claim 149 words
A method of delivering an expandable stent across a channel connecting a vein to an adjacent artery, the method comprising the steps of: providing a stent delivery device including an elongate member comprising a distal end, the elongate member comprising an expandable member and a nose cone on the distal end, and a stent in a contracted condition on the expandable member; inserting the elongate member into an outer sheath to cover the stent, the outer sheath engaging the nose cone to provide a substantially smooth transition therebetween; advancing the distal end of the elongate member along the vein until the nose cone is advanced into the channel; positioning the stent across the channel; withdrawing the outer sheath proximally to expose the stent within the channel; expanding the stent to an enlarged condition within the channel with the expandable member; and withdrawing the elongate member from the patient's body.
Claim 3
Dependent Claim 27 words
The method of claim 1 , wherein the elongate member includes a shoulder proximate the expandable member for preventing substantial proximal movement of the stent received thereon.
Claim 4
Dependent Claim 27 words
The method of claim 1 , wherein the nose cone at least partially dilates the channel when the distal end of the catheter body is advanced therethrough.
Claim 5
Dependent Claim 31 words
The method of claim 1 , wherein the outer sheath includes perfusion holes therethrough to allow continued flow of blood along the artery when the stent is positioned across the channel.
Claim 6
Dependent Claim 31 words
The method of claim 1 , wherein the nose cone includes perfusion holes therethrough to allow continued flow of blood along the artery when the stent is positioned across the channel.
Claim 7
Dependent Claim 30 words
The method of claim 1 , wherein the stent delivery device includes an externally observable marker, and wherein the marker is observed when the stent is positioned across the channel.
Claim 8
Dependent Claim 22 words
The method of claim 1 , further comprising the step of dilating the channel with an expandable member on the outer sheath.
Claim 9
Dependent Claim 30 words
The method of claim 1 , wherein the outer sheath includes an outer protrusion, and wherein the protrusion produces a tactile indication when the stent is positioned across the channel.
Claim 10
Independent Claim 124 words
A method for delivering a stent across a channel between two adjacent blood vessels, the method comprising: providing a delivery device comprising an elongate member including a nose cone on a distal end of the elongate member, a stent in a contracted condition on the distal end adjacent the nose cone, and a sheath covering the stent, the sheath engaging the nose cone to provide a substantially smooth transition therebetween; advancing the distal end of the elongate member along the first blood vessel until the nose cone is advanced into the channel; positioning the stent across the channel; withdrawing the sheath to expand the stent to an enlarged condition to engage tissue surrounding the channel; and withdrawing the elongate member from the patient's body.
Claim 11
Independent Claim 124 words
A method for delivering a stent across a channel between two adjacent blood vessels, the method comprising: providing a delivery device comprising an elongate member including a nose cone on a distal end of the elongate member, a stent in a contracted condition on the distal end adjacent the nose cone, and a sheath covering the stent, the sheath engaging the nose cone to provide a substantially smooth transition therebetween; advancing the distal end of the elongate member along the first blood vessel until the nose cone is advanced into the channel; positioning the stent across the channel; withdrawing the sheath to expand the stent to an enlarged condition to engage tissue surrounding the channel; and withdrawing the elongate member from the patient's body.
Claim 12
Dependent Claim 25 words
The method of claim 9 , wherein the nose cone at least partially dilates the channel when the nose cone is advanced through the channel.
Claim 13
Dependent Claim 22 words
The method of claim 10 , further comprising withdrawing and advancing the nose into the channel multiple times to dilate the channel.
Claim 14
Dependent Claim 70 words
The method of claim 9 , wherein the elongate member comprises an expandable member on the distal end, the stent being provided on the expandable member, and wherein the step of withdrawing the sheath to expand the stent comprises: withdrawing the sheath to expose the stent within the channel; and expanding the expandable member to forcibly expand the stent to the enlarged condition to substantially engage tissue surrounding the channel.
Claim 15
Dependent Claim 48 words
The method of claim 9 , wherein the stent is at least partially self-expanding, and wherein the step of withdrawing the sheath to expand the stent comprises withdrawing the sheath to expose the stent, whereupon at least a portion of the stent expands automatically to the enlarged condition.
Claim 16
Dependent Claim 18 words
The method of claim 9 , further comprising creating the channel between the first and second blood vessels.
Claim 17
Dependent Claim 27 words
The method of claim 14 , wherein the step of creating the channel comprises advancing a guidewire through the tissue between the first and second blood vessels.
Claim 18
Dependent Claim 33 words
The method of claim 15 , wherein the step of advancing the elongate member comprises advancing the elongate member over the guidewire, thereby advancing the nose cone over the guidewire into the channel.
Claim 19
Dependent Claim 58 words
The method of claim 9 , wherein the step of advancing the distal end of the elongate member comprises advancing the nose cone through the channel into the second blood vessel, and wherein at least one of the nose cone and the sheath includes perfusion holes therethrough to allow continued flow of blood along the second blood vessel.
Claim 20
Dependent Claim 29 words
The method of claim 9 , wherein the delivery device includes an externally observable marker, and wherein the marker is observed when the stent is positioned across the channel.
Claim 21
Dependent Claim 21 words
The method of claim 9 , further comprising the step of dilating the channel with an expandable member on the sheath.
Claim 22
Dependent Claim 29 words
The method of claim 9 , wherein the sheath includes an outer protrusion, and wherein the protrusion produces a tactile indication when the stent is positioned across the channel.
Claim 23
Dependent Claim 35 words
The method of claim 9 , wherein the advancing step comprises advancing the distal end of the elongate member percutaneously into a patient's vasculature until the distal end is disposed within the first blood vessel.
Claim 24
Independent Claim 184 words
A method for delivering a stent across a channel between two adjacent blood vessels of a patient, the method comprising: providing a delivery device comprising an elongate member including a nose cone and an expandable member on a distal end of the elongate member, a stent in a contracted condition on the expandable member on the distal end adjacent the nose cone, and a sheath covering the stent, the sheath engaging the nose cone to provide a substantially smooth transition therebetween; creating a channel through tissue between first and second adjacent blood vessels; advancing the distal end of the elongate member from a percutaneous entry site into the patient's vasculature and through the first blood vessel until the nose cone is advanced into the channel; positioning the stent across the channel such that the stent extends into at least one of the first and second blood vessels; withdrawing the sheath to expose the stent within the channel; expanding the expandable member to expand the stent to an enlarged condition to engage tissue surrounding the channel; and withdrawing the elongate member from the patient's body.
Claim 25
Independent Claim 184 words
A method for delivering a stent across a channel between two adjacent blood vessels of a patient, the method comprising: providing a delivery device comprising an elongate member including a nose cone and an expandable member on a distal end of the elongate member, a stent in a contracted condition on the expandable member on the distal end adjacent the nose cone, and a sheath covering the stent, the sheath engaging the nose cone to provide a substantially smooth transition therebetween; creating a channel through tissue between first and second adjacent blood vessels; advancing the distal end of the elongate member from a percutaneous entry site into the patient's vasculature and through the first blood vessel until the nose cone is advanced into the channel; positioning the stent across the channel such that the stent extends into at least one of the first and second blood vessels; withdrawing the sheath to expose the stent within the channel; expanding the expandable member to expand the stent to an enlarged condition to engage tissue surrounding the channel; and withdrawing the elongate member from the patient's body.
Claim 26
Dependent Claim 28 words
The method of claim 1 , wherein the stent extends into at least one of the vein and the artery when the stent is expanded within the channel.

References Cited (Backward Citations)

US5733325A Cited
US5573508A Cited
US5766203A Cited
US5925054A Cited
US5797920A Cited
US5676670A Cited
US5911752A Cited
US5772669A Cited
US5843027A Cited
US5792144A Cited
US5891154A Cited
US5913895A Cited
US5855600A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2004-12-17 2005-06-18 2005-12-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2008-12-17 2009-06-18 2009-12-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2012-12-17 2013-06-18 2013-12-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag